MedPath

The relation of between glucose variability and HbA1c, GA and 1,5AG in diabetes patients with insulin therapy using Continuous Glucose Monitoring system (iPro2) cross sectional study

Not Applicable
Conditions
Diabetes mellitus
Registration Number
JPRN-UMIN000019727
Lead Sponsor
niversity of Occupational and Environmental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) With erythropoietin for renal anemia (2)With anemia (Hb<10 g/dl) (3) With CKD and cirrhosis (4) With abnormal hemoglobinemia (5) With nephrotic syndrome (6)With steroid (7)With acarbose (8) hospitalized patients and discharge within two months (9) Considered as inadequate by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath